Jiangsu Weiqida Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is AZITHROMYCIN DIHYDRATE, with a corresponding US DMF Number 30887.
Remarkably, this DMF maintains an Active status since its submission on December 29, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 13, 2021, and payment made on June 24, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II